The performance of different propensity-score methods for estimating differences in proportions (risk differences or absolute risk reductions) in observational studies by Austin, Peter C
Research Article
Received 2 December 2009, Accepted 15 December 2009 Published online 27 January 2010 in Wiley Interscience
(www.interscience.wiley.com) DOI: 10.1002/sim.3854
The performance of different propensity-score
methods for estimating differences in
proportions (risk differences or absolute risk
reductions) in observational studies
Peter C. Austina,b∗†
Propensity score methods are increasingly being used to estimate the effects of treatments on health outcomes using observational
data. There are four methods for using the propensity score to estimate treatment effects: covariate adjustment using the
propensity score, stratiﬁcation on the propensity score, propensity-score matching, and inverse probability of treatment weighting
(IPTW) using the propensity score. When outcomes are binary, the effect of treatment on the outcome can be described using
odds ratios, relative risks, risk differences, or the number needed to treat. Several clinical commentators suggested that risk
differences and numbers needed to treat are more meaningful for clinical decision making than are odds ratios or relative
risks. However, there is a paucity of information about the relative performance of the different propensity-score methods for
estimating risk differences. We conducted a series of Monte Carlo simulations to examine this issue. We examined bias, variance
estimation, coverage of conﬁdence intervals, mean-squared error (MSE), and type I error rates. A doubly robust version of
IPTW had superior performance compared with the other propensity-score methods. It resulted in unbiased estimation of
risk differences, treatment effects with the lowest standard errors, conﬁdence intervals with the correct coverage rates, and
correct type I error rates. Stratiﬁcation, matching on the propensity score, and covariate adjustment using the propensity score
resulted in minor to modest bias in estimating risk differences. Estimators based on IPTW had lower MSE compared with
other propensity-score methods. Differences between IPTW and propensity-score matching may reﬂect that these two methods
estimate the average treatment effect and the average treatment effect for the treated, respectively. Copyright © 2010 John
Wiley & Sons, Ltd.
Keywords: propensity score; observational study; binary data; risk difference; number needed to treat; matching; IPTW; inverse
probability of treatment weighting; propensity-score matching
1. Introduction
In randomized controlled trials, the effect of treatment on dichotomous outcomes can be reported using a variety of
measures of treatment effect: the odds ratio, the relative risk (and the associated relative risk reduction), the absolute
risk reduction, and the number needed to treat (NNT) (the reciprocal of the absolute risk reduction). Schechtman [1]
argues that both relative and absolute measures should be reported. Cook and Sackett [2] argue that for clinical decision
making the NNT is more meaningful than the relative risk, relative risk reduction, or the odds ratio. Jaeschke et al.
[3] suggest that the odds ratio and the relative risk provide limited information. Finally, Sinclair and Bracken [4] argue
that clinically important questions are best addressed using relative risks, relative risk reductions, risk differences, and
the NNT. In the face of these proposals, some medical journals require that the NNT be reported for any randomized
controlled trial with a dichotomous outcome [5]. Common to all these recommendations is the agreement that limited
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information is provided by relative measures of treatment effect such as the odds ratio or the relative risk. Furthermore,
a common theme is that risk differences and numbers needed to treat can be of greater importance for clinical decision
making than are relative risks and odds ratios.
Researchers are increasingly using observational studies to estimate the effect of treatment on outcomes. In non-
randomized studies, unlike in randomized trials, treated subjects often differ systematically from untreated subjects.
Therefore, outcomes cannot be compared directly between treated and untreated subjects. Statistical methods must be
used to adjust for systematic differences between treated and untreated subjects when estimating the effect of treatment
on outcomes. Propensity-score methods are increasingly being used to eliminate the impact of treatment-selection bias
when estimating the effect of treatments or exposures on outcomes when using observational data. When outcomes
are dichotomous, propensity-score methods allow for estimation of risk differences, relative risks, and odds ratios. The
performance of different propensity-score methods for estimating relative risks and odds ratios has been extensively
studied [6--8]. However, there is a paucity of information about the performance of different propensity-score methods
for estimating risk differences. Given the increasing popularity of propensity-score methods and the clinical importance
of both the absolute risk reduction and the NNT, it is important to examine the performance of different propensity-
score methods for estimating these quantities. Understanding the performance of different propensity-score methods for
estimating absolute risk reductions and NNT will allow for the estimation of more clinically meaningful measures of
treatment effect using observational data.
The objective of the paper is to examine the performance of different propensity-score methods for estimating risk
differences (or absolute risk reductions). The paper is structured as follows. In Section 2, we brieﬂy review different
propensity-score methods for estimating risk differences. In Section 3, we describe an extensive series of Monte Carlo
simulations to examine the performance of different propensity-score methods for estimating risk differences. In Section
4, we present an empirical case study in which we compare the estimates of the effect of beta-blocker therapy on survival
using a large sample of patients hospitalized with heart failure. Finally, in Section 5 we summarize our ﬁndings.
2. Review of different propensity-score methods
The propensity score is the probability of treatment selection conditional on observed baseline covariates [9,10].
Rosenbaum and Rubin [9] demonstrated that conditional on the propensity score, the distribution of observed baseline
covariates is independent of treatment selection. In this section we brieﬂy review four methods of using the estimated
propensity score to estimate absolute risk reductions (i.e. differences in proportions or risk differences). The ﬁrst three,
stratiﬁcation on the propensity score, matching on the propensity score, covariate adjustment using the propensity score,
were proposed by Rosenbaum and Rubin in their initial article on the propensity score [9]. The fourth, inverse probability
of treatment weighting (IPTW), using the propensity score was subsequently developed by Rosenbaum [11].
2.1. Stratiﬁcation on the propensity score
Stratiﬁcation (or subclassiﬁcation) on the propensity score involves comparing outcomes between treated and untreated
subjects within strata deﬁned by the propensity score. The most common approach is to use ﬁve, approximately equally
sized strata deﬁned by the quintiles of the propensity score. The effect of treatment on outcomes is estimated within
each stratum. Stratum-speciﬁc treatment effects are then pooled to obtain an overall treatment effect. Rosenbaum and
Rubin demonstrated that stratifying on the quintiles of the estimated propensity score eliminates approximately 90
per cent of the bias due to the measured confounders [9].
Assume that pT,i and pC,i denote the proportion of treated and untreated subjects, respectively, in the ith stratum
that experience the event. Then the stratum-speciﬁc risk difference can be estimated as i = pT,i −pC,i. The pooled
estimate of the risk difference is then equal to S=(1/K)
K
i=1i, where K denotes the number of strata (K =5w h e n
stratiﬁcation on the quintiles of the propensity score is employed). The variance of each estimated stratum-speciﬁc
risk difference can be estimated using standard methods for estimating the variance of differences in proportions. The
stratum-speciﬁc variances can then be pooled to obtain an overall estimate of the variance of the pooled risk difference.
Let nC,i and nT,i denote the number of untreated and treated subjects in the ith strata. Then the variance of i can be
estimated by
pT,i ×(1−pT,i)
nT,i
+
pC,i ×(1−pC,i)
nC,i
The variance of S can be estimated by pooling the stratum-speciﬁc variances: var(S)=
K
i=1(1/K)2var(i).
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2.2. Matching on the propensity score
Propensity-score matching entails forming matched sets of treated and untreated subjects with similar values of the
propensity score. Although there are different approaches to matching, the most common approach in the medical
literature is nearest neighbor pair-matching without replacement within speciﬁed calipers of the propensity score [12--14].
Using this approach, pairs of treated and untreated subjects are formed such that the propensity score of the matched
subjects lies within a speciﬁed distance of one another (the caliper width). While a wide variety of calipers have been used
in the medical literature [12--14], there has been little research into the relative performance of different propensity-score
matching methods [15].
Once a propensity-score matched sample has been formed, the absolute risk reduction can be estimated as the difference
between the proportion of untreated subjects experiencing the outcome and the proportion of treated subjects experiencing
the outcome in the matched sample. In propensity-score matched analyses, one should account for the matched nature
of the sample when estimating the signiﬁcance of the treatment effect [16]. Thus, the statistical signiﬁcance of the risk
difference can be tested using McNemar’s test for correlated binomial proportions [17]. Similarly, conﬁdence intervals
for the difference in proportions can be constructed using methods that account for the matched nature of the sample
[17]. Assume that in the matched sample, there are a pairs in which both the treated and the untreated subjects experience
the event; b pairs in which the treated subject experiences the event, whereas the untreated subject does not; c pairs in
which the untreated subject experiences the event, whereas the treated subject does not; and d pairs in which both the
treated and the untreated subjects do not experience the event. The difference in the probability of the event between
the treated and the untreated subjects is estimated by (b−c)/n, where n is the number of matched pairs. The variance
of the difference in proportions is estimated by ((b+c)−(c−b)2/n)/n2 [17].
2.3. Inverse probability of treatment weighting
Let Z denote treatment assignment (Z =1 denoting treatment; Z =0 denoting absence of treatment). Furthermore, let e
denote the propensity score. The inverse probability of treatment is deﬁned as Z/e+(1−Z)/(1−e). For each subject,
it is equal to the inverse of the probability of receiving the treatment that the subject received. Rosenbaum developed
model-based direct adjustment as an extension to conventional direct standardization or adjustment [11]. Model-based
direct adjustment weights subjects by the inverse of the probability of treatment. Weighting by the inverse probability of
treatment results in a synthetic population in which treatment assignment is independent of measured baseline covariates.
Lunceford and Davidian [18] provide a review of methods for estimating treatment effects that use weighting by the
inverse of the probability of treatment. They describe several estimators that use IPTW, of which we describe two in
this section. Let Yi denote the outcome for the ith subject, Zi denote the treatment status of the ith subject, whereas ˆ ei
denote the estimated propensity score for this subject. Then the ﬁrst IPTW estimator of the risk difference, originally
proposed by Rosenbaum [11], is
ˆ IPTW1=
1
N
N 
i=1
ZiYi
ˆ ei
−
1
N
N 
i=1
(1−Zi)Yi
1−ˆ ei
(1)
where N denotes the number of subjects in the sample. We refer to the estimator as IPTW1. A second estimator described
by Lunceford and Davidian [18] is known as a doubly robust estimator. It requires specifying both the propensity-
score model as well as a regression model relating the expected outcome to treatment and baseline covariates. Let
mz(X,z)=E(Y|Z =z,X). Then
ˆ DR=
1
N
N 
i=1
ZiYi −(Zi −ˆ ei)m1(Xi, ˆ a)
ˆ ei
−
1
N
N 
i=1
(1−Zi)Yi −(Zi −ˆ ei)m0(Xi, ˆ a)
1−ˆ ei
(2)
ˆ DR has a ‘double-robustness’ property in that the estimator remains consistent if either the propensity-score model is
correctly speciﬁed or if both the outcomes regression models are correctly speciﬁed [18]. We refer to this estimator as
the IPTW-DR estimator. Lunceford and Davidian provide estimates of the variance for both ˆ IPW1 and ˆ DR.
2.4. Covariate adjustment using the propensity score
In covariate adjustment using the propensity score, the effect of treatment on the outcome is estimated by the regression
of the outcome on an indicator variable denoting treatment assignment and the propensity score. This is the most
commonly used propensity-score method in the medical literature [19,20]. Logistic regression would be the natural
regression model to implement when the outcome is binary. However, with logistic regression the odds ratio, rather
than the risk difference, is the measure of effect. One could attempt to use a generalized linear model with a Binomial
distribution and the identify link function. Although this would allow for estimation of risk differences, the identify link
Copyright © 2010 John Wiley & Sons, Ltd. Statist. Med. 2010, 292137--2148
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function does not constrain the predicted probability to lie between 0 and 1. This can lead to computational problems
and lack of model convergence in practice. As an alternative, one could use a linear regression model estimated using
ordinary least squares (OLS):
Yi =0+Zi +1ˆ ei +εi,ε i ∼N(0,2) (3)
where Zi and ˆ ei denote the treatment assignment and estimated propensity score, respectively, for the ith subject. The
estimated regression coefﬁcient for the treatment indicator, ˆ , would be used to estimate the reduction in the probability
of the outcome due to treatment. The standard error of the estimated difference in proportion could be the model-based
estimated standard error of the regression coefﬁcient ˆ . A limitation of this approach is that it ignores the fact that the
outcomes are dichotomous. Thus, the predicted probability of the event may not be constrained to lie between 0 and
1. Furthermore, the assumptions for the distribution of the error terms may no longer be satisﬁed, since the variance
of a predicted probability is not uniform but is a function of the proportion itself [21]. Although it is unlikely that this
approach would be considered in practice for estimating risk differences, we have included it in the current study for
comparative purposes.
3. Monte Carlo simulations
We used Monte Carlo simulations to examine the performance of different propensity-score methods. We examined
Type I error, bias, variance estimation, coverage of conﬁdence intervals, and mean-squared error (MSE).
3.1. Methods
We randomly generated data so that they would be similar to the data considered in the case study in Section 4. In
particular, we simulated data so that approximately 25 per cent of the sample was exposed to the treatment. Furthermore,
we simulated data such that the probability of the outcome would be approximately 0.29 if all subjects in the population
were not exposed. We then examined scenarios in which the risk differences between the treated and the untreated
subjects were 0, −0.02, −0.05, −0.10, and −0.15 (i.e. absolute reductions in the probability of the outcome due to
treatment were 0, 0.02, 0.05, 0.10, and 0.15).
As alluded to in Section 2.4, it is difﬁcult to use a conditional data-generating process to generate binary outcomes
and exposure such that the treatment causes a speciﬁc risk difference. Our data-generating process used the fact that
risk differences are collapsible: the average subject-speciﬁc risk difference is equal to the population or marginal risk
difference [22]. We used a recently described data-generating process for simulating data in which treatment induces a
speciﬁed risk difference [23]. This is a modiﬁcation of a data-generating process for inducing marginal odds ratios of
speciﬁc magnitudes that has been described elsewhere [7,24]. We describe this method brieﬂy.
First, we randomly generated 10 independent covariates (X1−X10) from a standard normal distribution for each of
10000 subjects. We then assumed that the following logistic regression model related the probability of the outcome to
these covariates and an indicator variable (Z) denoting treatment:
logit(pi,outcome)=0,outcome+Zi +LX1,i +LX2,i +LX3,i
+MX4,i +MX5,i +MX6,i
+H X7,i +H X8,i +H X9,i +VHX10,i (4)
In the above regression model, pi,outcome denotes the probability of the outcome for the ith subject and  denotes
the log-odds ratio relating treatment to the outcome. The regression coefﬁcients for the baseline covariates were set
as follows: L =log(1.1), M =log(1.25), H =log(1.5), and VH=log(2). These are intended to reﬂect low, medium,
h i g h ,a n dv e r yh i g hs i z e s .W eﬁ x e dt h ev a l u eo f0,outcome=log(0.29/0.71) so that the probability of the event occurring
in the population if all subjects were untreated would be approximately 0.29 (to reﬂect the scenario observed in the
case study in Section 4). For a ﬁxed value of , we determined the model-based predicted probability of the outcome
for each subject assuming that the entire population was untreated. The average predicted probability of the outcome if
all subjects are untreated is referred to as the marginal probability of the outcome if untreated. We then determined the
model-based predicted probability of the outcome for each subject assuming that the entire population was treated. The
average predicted probability of the outcome if all subjects are treated is referred to as the marginal probability of the
outcome if treated. The difference between the two marginal probabilities is the marginal (or population-average) risk
difference. Since the risk difference is collapsible, the marginal risk difference is equal to the average subject-speciﬁc
risk difference [22]. We repeated the above process 1000 times and determined the average risk difference over 1000
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simulated data sets. We then used an iterative process described elsewhere [23], to select the value of  that resulted
in the desired non-null risk difference. For a risk difference of 0,  was set to 0. For risk differences of −0.02, −0.05,
−0.10, and −0.15, the required value of  equaled 0.8935633, 0.7493734, 0.5446253, and 0.3769236, respectively. Note
that since we are estimating marginal or population-average risk differences, the value of  selected will depend on the
distribution of baseline covariates in the population.
For each risk difference (0, −0.02, −0.05, −0.10, and −0.15), we randomly generated 1000 data sets with the
required risk difference. The different propensity-score methods described in Section 2 were used to estimate the risk
difference due to treatment. For propensity-score matching, we matched subjects on the logit of the propensity score
using a caliper of width equal to 0.2 of the standard deviation of the logit of the propensity score [25,26]. We used three
different versions of the doubly robust estimator IPTW-DR. The ﬁrst used the correctly speciﬁed regression model to
predict outcomes (regressed outcomes on treatment and X1−X10). We refer to this method as IPTW-DR-1. The second
version used a mis-speciﬁed version of the outcomes regression model. In this model, the outcome was regressed on
an indicator for treatment status and the six variables that had a low or moderate effect on the outcome (X1−X6). The
four variables that had a high or very high effect on the outcome were omitted from this regression model. We refer to
this method as IPTW-DR-2. The third version also used a mis-speciﬁed version of the outcomes regression model. In
this model, the outcome was regressed only on an indicator variable denoting treatment status. We refer to this method
as IPTW-DR-3. We also estimated the crude (unadjusted) risk difference in each simulated data set.
For each true risk difference, we calculated the mean estimated risk difference across the 1000 simulated data sets.
We also calculated the mean estimated standard error of the estimated risk differences across the 1000 data sets and
the proportion of estimated 95 per cent conﬁdence intervals that contained the true risk difference. We computed the
MSE of the estimate. We also determined the ratio of the mean estimated standard error across the 1000 simulated data
sets to the standard deviation of the estimated risk differences across the 1000 simulated data sets. When the true risk
difference was 0 (null treatment effect), we estimated the empirical type I error rate as the proportion of simulated data
sets in which the null hypothesis that the risk difference was equal to zero was rejected at a 0.05 signiﬁcance level.
3.2. Results
The mean estimated risk difference, mean estimated standard error, empirical coverage rates of 95 per cent conﬁdence
intervals, MSE, and ratio of mean standard error of estimates to the standard deviation of the estimated risk differences
are reported in Table I for each of the different propensity-score methods and for each of the ﬁve different true risk
differences. We discuss the performance of the different propensity-score methods on each of these metrics in the
following paragraphs.
One observes that the four estimators that used IPTW resulted in essentially unbiased estimation of the true risk
difference. Matching on the propensity score resulted in estimated risk differences that were modestly biased away
from the null treatment effect: the estimates displayed a greater absolute risk reduction compared with the true absolute
risk reduction. Similarly, stratiﬁcation on the quintiles of the propensity score resulted in estimated risk differences
that displayed modest bias. However, for stratiﬁcation, the bias was toward the null treatment effect. Finally, covariate
adjustment using the propensity score resulted in estimates that displayed a bias similar to that of propensity-score
matching. When the true risk difference was different from 0, propensity-score matching resulted in relative biases
ranging from 15 to 21 per cent, with the relative bias increasing with the true risk difference. Stratiﬁcation on the
quintiles of the propensity score resulted in relative biases ranging from −9t o−75 per cent, with relative bias increasing
in absolute value as the true risk difference decreased in absolute magnitude. Covariate adjustment using the propensity
score resulted in relative biases ranging from 14 to 16 per cent.
For a given true risk difference, the mean standard error of the estimated risk difference was minimized when
propensity-score weighting using the doubly robust estimator and the correctly speciﬁed outcomes model (IPTW-DR-1)
wasused.Forsomevaluesofthetrueriskdifference,eithercovariateadjustmentusingthepropensityscoreorstratiﬁcation
on the quintiles of the propensity score resulted in estimates with the same mean standard error as IPTW-DR-1. For a
given true risk difference, the mean standard error of the estimated risk difference was largest when propensity-score
matching was employed. For some values of the true risk difference, IPTW1, IPTW-DR-2, or IPTW-DR-3 had estimates
with the mean standard error as large as that of propensity-score matching.
IPTW-DR-1 had 95 per cent conﬁdence intervals whose coverage rates ranged from 0.953 to 0.964 across the ﬁve
different scenarios. The other methods based on IPTW resulted in conﬁdence intervals that were conservative—the
coverage rates of the 95 per cent conﬁdence intervals exceeded the advertised rate. For propensity-score matching, the
empirical coverage rates were approximately correct when the true risk difference was 0 or −0.02. However, it was
substantially lower for larger risk differences. Stratiﬁcation on the quintiles of the propensity score always produced
95 per cent conﬁdence intervals whose empirical coverage rates were at most 0.710. Covariate adjustment using the
propensity score resulted in conﬁdence intervals with coverage rates similar to those of propensity-score matching.
Copyright © 2010 John Wiley & Sons, Ltd. Statist. Med. 2010, 292137--2148
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For all values of the true risk difference, IPTW-DR-1 resulted in estimates with the lowest MSE. However, in all
instances, the other estimates based on IPTW had very similar estimates to that of the IPTW-DR-1 estimate. Stratiﬁcation
on the quintiles of the propensity score resulted in estimates with MSE that were approximately 3 to 3.5 times greater
than those of IPTW-DR-1. Matching resulted in estimates whose MSE was between 1.5 and 17 times greater than those
of IPTW-DR-1.
For propensity-score matching, the ratio between the mean standard error of the estimated risk differences and the
standard deviation of the estimated risk differences across the 1000 simulated data sets ranged from 0.995 to 1.021,
indicating that the sampling variability of the estimated risk difference was well approximated by the estimated standard
error of the risk difference. Similarly, for the IPTW-DR-1 estimator, this ratio ranged from 1.000 to 1.028. However, for
IPTW1, IPTW-DR-2, and IPTW-DR-3, this ratio ranged from 1.170 to 1.270, indicating that the estimated standard error
of the estimated risk difference was over-estimating the standard deviation of the sampling distribution by approximately
17 to 27 per cent. For stratiﬁcation, this ratio ranged from 0.996 to 1.029, whereas for covariate adjustment using the
propensity score the ratio ranged from 0.943 to 1.05. Thus, for stratiﬁcation, the estimated standard error of the estimated
risk difference tended to closely approximate the standard deviation of the sampling distribution of the estimated risk
difference.
When the true risk difference was equal to 0, the empirical type I error rates were estimated by the proportion of
simulated data sets in which the null hypothesis of a null risk difference was rejected. The empirical type I error rates
were as follows: covariate adjustment using the propensity score: 0.067; stratiﬁcation on the quintiles of the propensity
score: 0.301; propensity-score matching: 0.064; IPTW1: 0.022; IPTW-DR-1: 0.047; IPTW-DR-2: 0.022; and IPTW-DR-
3: 0.018. Owing to our use of 1000 simulated data sets, any empirical type I rate that is higher than 0.0635 or lower than
0.0365 would be signiﬁcantly different from 0.05 using a standard normal approximation to the binomial distribution
test. Thus, only the IPTW-DR-1 estimator had an observed empirical type I error rate that was not signiﬁcantly different
from 0.05. All the other propensity-score methods had empirical type I error rates that were signiﬁcantly different from
0.05. However, propensity-score matching and covariate adjustment using the propensity score had empirical type I error
rates that were approximately equal to the nominal level. The other IPTW estimators had empirical type I error rates
that were less than 0.05 (0.018 to 0.022).
4. Case study
4.1. Data sources
Detailed clinical data were obtained by a retrospective chart review on a sample of 7613 patients discharged alive with
a diagnosis of heart failure between 1 April 1999 and 31 March 2001 from 103 acute care hospitals in Ontario, Canada.
Further detail of the data obtained is provided elsewhere [27,28]. These data were collected as a part of the Enhanced
Feedback for Effective Cardiac Treatment (EFFECT) Study, an ongoing initiative intended to improve the quality of
care for patients with cardiovascular disease in Ontario [28]. Data on patient demographics, vital signs at presentation,
and results of physical examination at presentation, medical history, and results of laboratory tests were collected for
this sample. Subjects with missing data on key continuous baseline covariates were excluded from the current study.
In the current study, we examined receipt of a prescription for a beta-blocker at discharge as the exposure of interest.
The demographic and the clinical characteristics of the treated and the untreated subjects are described in Table II.
Continuous and categorical variables were compared between the treated and the untreated subjects using the Wilcoxon
Rank Sum test and the Chi-squared test, respectively. Standardized differences are also reported for comparing the mean
of variables between treatment groups [29]. Systematic differences in several variables, including age, systolic blood
pressure, heart rate, history of previous myocardial infarction, history of chronic obstructive pulmonary disease (COPD),
and dementia, were observed between the treatment groups. Overall, 27.3 per cent of patients received a prescription
for a beta-blocker at discharge. The outcome of interest was death within 1 year of hospital discharge. 27.7 per cent of
the subjects died within 1 year of hospital discharge.
4.2. Statistical analyses
An indicator variable denoting receipt of a beta-blocker prescription at hospital discharge was regressed on the 28
baseline characteristics described in Table II using a logistic regression model. The estimated propensity score was the
predicted probability of receiving a beta-blocker prescription that was derived from the ﬁtted logistic regression model.
Once the estimated propensity score had been obtained, the different propensity-score methods described in
Section 2 were used to estimate the absolute reduction in the probability of death within one year of discharge due to
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Table III. Estimated absolute risk reduction in case study.
Propensity score Absolute risk Ninety-ﬁve per cent conﬁdence interval
method reduction for the absolute risk reduction
Covariate adjustment using the propensity score 0.05 (0.027, 0.073)
Stratiﬁcation on the propensity score 0.053 (0.03, 0.077)
IPTW1 0.051 (0.024, 0.078)
IPTW-DR-1 0.05 (0.028, 0.073)
IPTW-DR-2 0.051 (0.026, 0.075)
Propensity-score matching 0.047 (0.022, 0.073)
receipt of a beta-blocker prescription. The associated NNT was the reciprocal of the absolute risk reduction. For
propensity-score matching, the treated and the untreated subjects were matched on the logit of the propensity score
using calipers of width equal to 0.2 of the standard deviation of the logit of the propensity score. We used two different
doubly robust estimators using IPTW. The ﬁrst used all 28 variables listed in Table II to predict mortality. The second
used a regression model that only contained an indicator variable for treatment with beta-blocker at hospital discharge.
4.3. Results
The estimated reduction in the probability of 1-year mortality for each of the propensity-score methods is reported in
Table III. The absolute reduction in the probability of death within one year of discharge due to receipt of a beta-blocker
prescription ranged from a low of 0.047 (4.7 per cent) for propensity-score matching to a high of 0.053 (5.3 per cent) for
stratiﬁcation on the quintiles of the propensity score. The estimated absolute risk reductions were qualitatively similar
across the different propensity-score methods. The associated numbers needed to treat ranged from a low of 18.9 ( 1
0.053)
for stratiﬁcation on the propensity score to a high of 21.3 ( 1
0.047) for propensity-score matching. The three different
methods that used IPTW produced very similar estimates of the absolute risk reduction (0.050 to 0.051).
The doubly robust IPTW estimator with the full outcome-regression model had the narrowest 95 per cent conﬁdence
interval (width =0.045). The simple IPTW1 estimator had a 95 per cent conﬁdence interval that was 20 per cent wider.
Propensity-score matching resulted in a 95 per cent conﬁdence interval that was 13 per cent wider than that of the
doubly robust method with the fully speciﬁed outcomes regression model. Similarly, stratiﬁcation on the quintiles of the
propensity score resulted in a 95 per cent conﬁdence interval that was 4 per cent wider than that of the doubly robust
methods.
5. Discussion
In this paper we used Monte Carlo simulations to examine the performance of different propensity-score methods for
estimating risk differences. The estimators based on using IPTW resulted in unbiased estimation of the risk differences.
The other propensity-score methods introduced minor to modest bias. The IPTW doubly robust estimator with the
correctly speciﬁed outcomes regression model resulted in estimates with the lowest estimated standard errors. Similarly,
this method resulted in estimates with the lowest MSE, although the other IPTW estimators were close competitors. The
IPTW doubly robust estimator with the correctly speciﬁed outcomes regression model resulted in conﬁdence intervals
with the advertised coverage rates, whereas those of other IPTW estimators had coverage rates that exceeded the
advertised levels. In some scenarios, propensity-score matching resulted in conﬁdence intervals whose coverage rates were
substantially lower than the advertised levels. Similarly, the IPTW doubly robust estimator with the correctly speciﬁed
outcomes regression model resulted in approximately correct type I error rates, whereas the other IPTW estimators had
type I error rates lower than the nominal level. Finally, we observed that the standard errors for stratiﬁcation, matching,
and the doubly robust IPTW estimator with the correctly speciﬁed regression model closely approximated the standard
deviation of the sampling distribution of the estimators.
In our case study, we observed that the different propensity-score methods resulted in qualitatively similar estimates
of the absolute reduction in the probability of mortality within 1 year due to receipt of a beta-blocker prescription at
hospital-discharge. Similarly, estimates of the NNT to avoid one death within 1 year were qualitatively similar across the
different methods (range 19–21). IPTW using the doubly robust estimator with the full regression model resulted in a
95 per cent conﬁdence interval with the narrowest width. Propensity-score matching resulted in a 95 per cent conﬁdence
interval that was 13 per cent wider than the doubly robust method.
When outcomes are binary, measures of treatment effect can be reported using odds ratios, relative risks, or risk
differences. Several studies have examined the performance of different propensity-score methods for estimating relative
Copyright © 2010 John Wiley & Sons, Ltd. Statist. Med. 2010, 292137--2148
2
1
4
5P. C. AUSTIN
risks and odds ratios. Austin et al. found that propensity-score methods result in biased estimation of conditional or
adjusted odds ratios [6]. Furthermore, propensity-score matching, stratiﬁcation on the propensity score, and covariate
adjustment using the propensity score result in sub-optimal inferences about marginal or population-average odds ratios
[7]. However, propensity-score methods allow for unbiased estimation of relative risks in the presence of a uniform
treatment effect [8]. When used for estimating relative risks, stratiﬁcation and matching displayed the variance–bias
trade-off: matching resulted in estimates with less bias, whereas stratiﬁcation resulted in estimates with lower variance
and greater precision [8]. In contrast to these prior studies examining estimation of odds ratios and relative risks, there
is a paucity of information on the performance of different propensity-score methods for estimating risk differences.
Clinical commentators have suggested that absolute risk reductions and numbers needed to treat provide important
information for clinical decision making that is lacking in relative measures of effect such as the odds ratio and the
relative risk [1--4].
Furthermore, some medical journals require that the NNT be reported for any randomized clinical trial with binary
outcomes [5]. These clinically meaningful measures of treatment effect can be easily computed using propensity-score
methods. The current study provides the ﬁrst comprehensive examination of the performance of the four different
propensity-score methods for estimating risk differences. Given the advantages of the absolute risk reduction and the
NNT for clinical decision making, we suggest that these measures of effect should also be reported for any observational
study with binary outcomes.
Based on the results of our Monte Carlo simulations, IPTW using the doubly robust estimator had the superior
performance of the different propensity-score methods examined. It resulted in essentially unbiased estimation of the
true risk difference, had the lowest standard error of the estimated risk difference, had the lowest MSE, resulted in 95
per cent conﬁdence intervals with approximately correct coverage rates, and had approximately correct type I error rates.
Each of the competing approaches had inferior performance on at least one of these metrics compared with the doubly
robust approach. A limitation of the doubly robust approach is the requirement that one specify an outcomes regression
model relating the outcome to baseline covariates. However, we found that if the outcomes model was mis-speciﬁed
through the omission of several predictor variables, then superior performance was still achieved relative to stratiﬁcation
or matching on the propensity score. Propensity-score matching and stratiﬁcation on the quintiles of the propensity score
are two commonly used approaches in the medical literature, whereas IPTW methods are rarely employed in the medical
literature [19,20]. When the comparison was restricted to stratiﬁcation and matching, one observed that matching had
superior performance for low to moderate effect sizes, whereas stratiﬁcation had superior performance for larger effect
sizes. However, matching resulted in an approximately correct type I error rate, whereas stratiﬁcation had a substantially
inﬂated type I error rate.
There has been limited comparison of methods that employ IPTW with other propensity-score methods in the literature.
Lunceford and Davidian [18] compared methods employing weighting via the propensity score with stratiﬁcation in
the context of a continuous outcome and a linear treatment effect. Some of our observations mirror their ﬁndings. For
instance, they note that stratiﬁcation is not a consistent estimator, resulting in biased estimation of linear treatment effects.
Furthermore, they note that the IPTW-DR-1 estimator has lower variance than the IPTW1 estimator, which reﬂects the
ﬁndings of our Monte Carlo simulations. In addition, Lunceford and Davidian observed that stratiﬁcation resulted in
estimates with higher MSE compared with IPTW-DR-1, and that conﬁdence intervals for stratiﬁed estimators did not have
the advertised coverage rates. The current study made two novel contributions. The ﬁrst was the focus on estimating risk
differences rather than differences in means. In randomized controlled trials of medical interventions, binary outcomes
are more prevalent than continuous outcomes [30]. Therefore, our focus on estimating risk differences may provide more
guidance to medical researchers examining the effects of treatments on health outcomes using observational data. The
second novel contribution was the inclusion of propensity-score matching and covariate adjustment using the propensity
score. Both of these methods are used more frequently than methods based on IPTW [19,20]. Propensity-score matching
is frequently used in the medical literature. It is important to determine its relative performance compared with the
competing methods for estimating risk differences.
The propensity score is a balancing score: conditional on the propensity score, the distribution of measured baseline
covariates is similar between the treated and the untreated subjects [9]. Several recent studies have compared the
relative ability of different propensity-score methods with balance measured baseline covariates between the treated and
the untreated subjects. Propensity-score matching has been shown to eliminate a greater proportion of the systematic
differences between the treated and the untreated subjects compared with stratiﬁcation on the propensity score [25,26,31].
Similarly, propensity-score matching eliminated a greater degree of the systematic differences between the treated and
the untreated subjects compared with covariate adjustment using the propensity-score [31]. Finally, in some settings,
propensity-score matching and IPTW using the propensity score eliminated systematic differences between the treated
and the untreated subjects to an approximately equivalent degree [31]. However, there were some scenarios in which
propensity-score matching eliminated a modestly greater proportion of the observed imbalance compared with IPTW
using the propensity score [31].
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A limitation to the use of methods based on IPTW is the paucity of methods that have been described in the literature
for assessing whether the propensity-score model has been correctly speciﬁed in this context. When stratiﬁcation or
matching on the propensity score is employed, a range of diagnostics have been described for assessing the adequacy
of the speciﬁcation of the propensity-score model [10,25,26,32]. However, there are limited descriptions of methods
to assess the goodness-of-ﬁt of the propensity-score model in the context of IPTW (one assumes that many methods
for matching could be adapted to the use of IPTW using the propensity score). Rubin writes ‘In rare situations, the
individually estimated probabilities (i.e. the estimated propensity scores) themselves may be used in the process of
estimating treatment effects ... If it is, the propensity-score estimation has to be conducted far more carefully. ... In
such cases, the estimated probabilities can be very inﬂuential on the estimated effects of treatment versus control, and
so the probabilities themselves must be very well-estimated. In such cases, diagnostics of the accuracy of the estimated
probabilities are appropriate, although diagnostics of the estimated underlying (logistic) regression coefﬁcients are
generally irrelevant’ [33]. Thus, a prelude to the greater use of methods based on IPTW using the propensity score may
be the development of diagnostics for assessing the accuracy of the estimated propensity scores.
The apparent superiority of IPTW using the propensity score compared with propensity-score matching may be worri-
some, given the popularity of the latter method [12--14]. However, a possible explanation for the discrepancies between
these two methods is that they are estimating different measures of effect. The econometrics literature differentiates
between the average treatment effect (ATE) and the average treatment effect for the treated (ATT) [34]. Imbens [34]
states that stratiﬁcation using the propensity score and IPTW using the propensity score allow one to estimate the ATE,
whereas matching on the propensity score allows one to estimate the ATT. The data-generating process in the current
study induced a speciﬁed ATE. Thus, the bias estimation that arose when using propensity-score matching may primarily
be a result of the fact that matching estimates the ATT, whereas stratiﬁcation and weighting estimate the ATE.
In conclusion, our study suggests that a greater use of methods based on IPTW should be used for estimating risk
differences in observational studies. This is particularly true when the interest is in estimating ATEs. Although the focus
in the past has been on odds ratios and relative risks, estimation of absolute risk reductions and numbers needed to treat
may provide greater information for clinical decision making.
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